Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges
Issued Date
2023-03-01
Resource Type
ISSN
16617827
eISSN
16604601
Scopus ID
2-s2.0-85151660479
Journal Title
International Journal of Environmental Research and Public Health
Volume
20
Issue
6
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Environmental Research and Public Health Vol.20 No.6 (2023)
Suggested Citation
Adachi T., El-Hattab A.W., Jain R., Nogales Crespo K.A., Quirland Lazo C.I., Scarpa M., Summar M., Wattanasirichaigoon D. Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges. International Journal of Environmental Research and Public Health Vol.20 No.6 (2023). doi:10.3390/ijerph20064732 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/81863
Title
Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges
Author's Affiliation
University Hospital Sharjah
College of Medicine
Ramathibodi Hospital
Graduate School of Medical Science
School of Humanities
National Health Security Office
Keio University School of Medicine
Universitat Autònoma de Barcelona
The Food and Drug Administration, Thailand Ministry of Public Health
Policlinico Universitario, Udine
Universidad de Chile
National Institutes of Health (NIH)
Childrens National Health System
The George Washington University
United Japanese-Researchers Around-the-World (UJA)
Dystrophic Epidermolysis Bullosa Research Association (DEBRA)
Policy Wisdom LLC
Thailand Medical Genetics and Genomics Association (TMGGA)
Asia Pacific Society of Human Genetics (APSHG)
MENA (Middle East and North Africa) Organization for Rare Diseases
Genetics Society of Thailand
Thai Rare Disease Foundation (ThaiRDF)
Asia Pacific Alliance of Rare Disease Organisations
European Reference Network for Hereditary Metabolic Disorders (MetabERN)
National Organization for Rare Disorders
Brains for Brain Foundation
Fundación Arturo López Pérez
College of Medicine
Ramathibodi Hospital
Graduate School of Medical Science
School of Humanities
National Health Security Office
Keio University School of Medicine
Universitat Autònoma de Barcelona
The Food and Drug Administration, Thailand Ministry of Public Health
Policlinico Universitario, Udine
Universidad de Chile
National Institutes of Health (NIH)
Childrens National Health System
The George Washington University
United Japanese-Researchers Around-the-World (UJA)
Dystrophic Epidermolysis Bullosa Research Association (DEBRA)
Policy Wisdom LLC
Thailand Medical Genetics and Genomics Association (TMGGA)
Asia Pacific Society of Human Genetics (APSHG)
MENA (Middle East and North Africa) Organization for Rare Diseases
Genetics Society of Thailand
Thai Rare Disease Foundation (ThaiRDF)
Asia Pacific Alliance of Rare Disease Organisations
European Reference Network for Hereditary Metabolic Disorders (MetabERN)
National Organization for Rare Disorders
Brains for Brain Foundation
Fundación Arturo López Pérez
Other Contributor(s)
Abstract
This document provides a comprehensive summary of evidence on the current situation of rare diseases (RDs) globally and regionally, including conditions, practices, policies, and regulations, as well as the challenges and barriers faced by RD patients, their families, and caregivers. The document builds on a review of academic literature and policies and a process of validation and feedback by a group of seven experts from across the globe. Panelists were selected based on their academic merit, expertise, and knowledge regarding the RD environment. The document is divided into five main sections: (1) methodology and objective; (2) background and context; (3) overview of the current situation and key challenges related to RDs covering six dimensions: burden of disease, patient journey, social impact, disease management, RD-related policies, and research and development; (4) recommendations; and (5) conclusions. The recommendations are derived from the discussion undertaken by the experts on the findings of this review and provide a set of actionable solutions to the challenges and barriers to improving access to RD diagnosis and treatment around the world. The recommendations can support critical decision-making, guiding efforts by a broad range of RDs stakeholders, including governments, international organizations, manufacturers, researchers, and patient advocacy groups.